Biotech Hunter
Biotech Hunter
Home
Companies
Trials
People
Search
Clinical Trials Directory
Explore 118,444 clinical trials worldwide
Search
Showing 85601-85650 of 118,444 trials
Active filters:
Status: Recruiting, Active, not recruiting, Enrolling by invitation, Not yet recruiting
Clinical Trials (118,444)
NCT06245330
A Phase I/II Study of AST-001 in Subjects With Advanced Solid Tumors
PHASE1/PHASE2
Recruiting
180 participants
Started: Jul 7, 2022 · Completed: Aug 31, 2027
2 conditions
1 sponsor
1 location
NCT05377281
Feasibility and Safety of AutoloGous UncondItioneD PEripheral Nerve Tissue Delivery to the Substantia Nigra (GUIDE)
PHASE1
Active, not recruiting
10 participants
Started: Jul 7, 2022 · Completed: Jun 30, 2027
1 condition
1 sponsor
1 location
NCT05573984
Natural History of PRPF31 Mutation-Associated Retinal Dystrophy
N/A
Active, not recruiting
50 participants
Started: Jul 7, 2022 · Completed: Feb 28, 2026
5 conditions
1 sponsor
7 locations
NCT05226871
Study for Participants Continuing From Pfizer-sponsored Palbociclib (a Study Medicine) Studies
PHASE2
Recruiting
35 participants
Started: Jul 7, 2022 · Completed: Dec 31, 2026
2 conditions
1 sponsor
22 locations
NCT05161195
Roll-over Study to Allow Continued Access to Ribociclib
PHASE4
Active, not recruiting
134 participants
Started: Jul 7, 2022 · Completed: Aug 14, 2030
1 condition
1 sponsor
74 locations
NCT04963153
Testing Combination Erdafitinib and Enfortumab Vedotin in Metastatic Bladder Cancer After Treatment With Chemotherapy and Immunotherapy
PHASE1
Active, not recruiting
30 participants
Started: Jul 7, 2022 · Completed: Dec 1, 2026
20 conditions
1 sponsor
10 locations
NCT05440929
Evaluation of the Acceptability, Appropriateness, and Feasibility/Usability of a Metastatic Breast-cancer Specific Prognostic Calculator Among Clinicians
N/A
Recruiting
15 participants
Started: Jul 7, 2022 · Completed: Aug 10, 2027
2 conditions
2 sponsors
1 location
NCT05505799
Community Medical Center, Continuous Quality Improvement Project, Rapid Sequence Intubation
NA
Active, not recruiting
700 participants
Started: Jul 7, 2022 · Completed: Jun 30, 2025
3 conditions
1 sponsor
1 location
NCT05783804
Plaque Reversal With Early, Aggressive Lipid Lowering Therapy
N/A
Recruiting
60 participants
Started: Jul 7, 2022 · Completed: Apr 30, 2027
1 condition
1 sponsor
1 location
NCT06012942
Prevalence and Long Term Effects of Frailty in Elderly Intensive Care Patients
N/A
Recruiting
300 participants
Started: Jul 7, 2022 · Completed: Dec 31, 2025
2 conditions
6 sponsors
5 locations
NCT04498221
Lymphatic Mapping Of Oropharyngeal Cancer
NA
Recruiting
150 participants
Started: Jul 7, 2022 · Completed: Jan 31, 2027
1 condition
2 sponsors
2 locations
NCT05758116
Tislelizumab Consolidation Therapy After Radiotherapy or Sequential Chemoradiation in Locally Advanced NSCLC Patients
PHASE2
Recruiting
20 participants
Started: Jul 7, 2022 · Completed: Jul 7, 2026
3 conditions
1 sponsor
1 location
NCT04805957
Validation Digital Bio-markers During Sulforaphane Treatment.
NA
Enrolling by invitation
10 participants
Started: Jul 7, 2022 · Completed: Jun 1, 2025
3 conditions
1 sponsor
1 location
NCT05413135
Study of ARO-APOC3 in Adults With Dyslipidemia
PHASE2
Active, not recruiting
418 participants
Started: Jul 7, 2022 · Completed: Sep 30, 2025
1 condition
1 sponsor
60 locations
NCT05282901
Efficacy and Safety of Pembrolizumab in Combination With Lenvatinib in Metastatic Uveal MElanoma Patients (PLUME)
PHASE2
Active, not recruiting
51 participants
Started: Jul 7, 2022 · Completed: Nov 15, 2026
1 condition
2 sponsors
1 location
NCT05361902
A First Step Towards Ultra-hypofractionation for Unfavourable Intermediate and High-risk Prostate Cancer
NA
Active, not recruiting
35 participants
Started: Jul 7, 2022 · Completed: Feb 28, 2027
1 condition
1 sponsor
1 location
NCT04919512
A Study of TAR-200 in Combination With Cetrelimab and Cetrelimab Alone in Participants With Muscle-Invasive Urothelial Carcinoma of the Bladder
PHASE2
Active, not recruiting
163 participants
Started: Jul 7, 2022 · Completed: Mar 7, 2027
1 condition
1 sponsor
109 locations
NCT04881799
Phentermine/Topiramate in Adolescents With Type 2 Diabetes and Obesity
EARLY_PHASE1
Active, not recruiting
13 participants
Started: Jul 7, 2022 · Completed: Jun 30, 2027
1 condition
1 sponsor
1 location
NCT05407610
Comparison of Conventional and Cooled Radiofrequency of the Genicular Nerves in Patients With Chronic Knee Pain
NA
Recruiting
400 participants
Started: Jul 7, 2022 · Completed: Sep 1, 2026
3 conditions
3 sponsors
15 locations
NCT05356884
Adolescent-mediated Family Diabetes Intervention: American Samoa
NA
Active, not recruiting
360 participants
Started: Jul 7, 2022 · Completed: Dec 31, 2025
1 condition
2 sponsors
1 location
NCT05351112
PMCF Study on the Safety, Performance and Clinical Benefits Data of the Anatomical Shoulder 2.0 Fracture System
N/A
Recruiting
78 participants
Started: Jul 7, 2022 · Completed: Jan 21, 2034
3 conditions
1 sponsor
1 location
NCT05152290
Safety of Cultured Allogeneic Adult Umbilical Cord Derived Mesenchymal Stem Cells for SCI
PHASE1
Recruiting
20 participants
Started: Jul 6, 2022 · Completed: Jan 31, 2026
1 condition
1 sponsor
2 locations
NCT04932148
INCremental Dialysis to Improve Health Outcomes in People Starting Haemodialysis (INCH-HD)
NA
Recruiting
372 participants
Started: Jul 6, 2022 · Completed: Aug 31, 2026
1 condition
4 sponsors
16 locations
NCT05381909
A Study of BGB-24714 as Monotherapy and With Combination Therapies in Participants With Solid Tumors
PHASE1
Active, not recruiting
157 participants
Started: Jul 6, 2022 · Completed: Nov 30, 2026
1 condition
1 sponsor
34 locations
NCT05179187
Non-invasive Brain Mapping of Movement Facilitation in Parkinson's Disease
NA
Recruiting
90 participants
Started: Jul 6, 2022 · Completed: Sep 30, 2026
1 condition
2 sponsors
1 location
NCT05291091
Phase 2 Study of EDG-5506 in Becker Muscular Dystrophy (GRAND CANYON)
PHASE2
Active, not recruiting
175 participants
Started: Jul 6, 2022 · Completed: Aug 31, 2026
1 condition
4 sponsors
51 locations
NCT05371834
Microwave Treatment of Common and Plantar Warts
NA
Active, not recruiting
119 participants
Started: Jul 6, 2022 · Completed: Mar 31, 2025
1 condition
2 sponsors
6 locations
NCT04896047
FGF19 and Chronic Kidney Disease
NA
Recruiting
170 participants
Started: Jul 6, 2022 · Completed: Feb 6, 2027
1 condition
1 sponsor
1 location
NCT06248944
AIOCC Italian Registry on Head and Neck Carcinomas
N/A
Recruiting
7,000 participants
Started: Jul 6, 2022 · Completed: Jul 6, 2027
1 condition
1 sponsor
7 locations
NCT05384860
Incorporating Acupuncture Into ERAS for Ambulatory Total Hip Replacement (THR) Surgery
NA
Recruiting
484 participants
Started: Jul 6, 2022 · Completed: Jan 31, 2026
3 conditions
1 sponsor
1 location
NCT04785300
ALSENLITE: Senolytics for Alzheimer's Disease
PHASE1/PHASE2
Enrolling by invitation
20 participants
Started: Jul 6, 2022 · Completed: Jun 30, 2026
2 conditions
1 sponsor
1 location
NCT05465538
SV2A in Older Adults
PHASE1/PHASE2
Recruiting
24 participants
Started: Jul 6, 2022 · Completed: Sep 30, 2025
1 condition
2 sponsors
1 location
NCT05391737
Cardiac Function in Swimming-Induced Pulmonary Edema (SIPE)
N/A
Recruiting
120 participants
Started: Jul 6, 2022 · Completed: Dec 31, 2026
4 conditions
1 sponsor
1 location
NCT05434663
Safety Study of Repeat Doses of SUSTOL in Adults
PHASE4
Active, not recruiting
300 participants
Started: Jul 6, 2022 · Completed: Oct 31, 2025
1 condition
1 sponsor
2 locations
NCT05219435
Study of NIVOLUMAB/IPILIMUMAB Maintenance in Unresectable Locally Advanced or Metastatic Urothelial Cancer
PHASE2
Active, not recruiting
66 participants
Started: Jul 6, 2022 · Completed: Dec 31, 2025
1 condition
2 sponsors
12 locations
NCT05337553
A Study to Evaluate the Efficacy and Safety of Taldefgrobep Alfa in Participants With Spinal Muscular Atrophy
PHASE3
Active, not recruiting
269 participants
Started: Jul 6, 2022 · Completed: Jan 31, 2026
3 conditions
1 sponsor
53 locations
NCT06109857
Bladder Bank (a Prospective Banking Study)
N/A
Recruiting
1,000 participants
Started: Jul 6, 2022 · Completed: Dec 1, 2027
1 condition
1 sponsor
1 location
NCT07179744
Regional Radiotherapy Omission in Low-Risk Node Positive Breast Cancer
N/A
Recruiting
635 participants
Started: Jul 6, 2022 · Completed: Jul 5, 2032
1 condition
2 sponsors
1 location
NCT05612100
Endocrine Therapy-Induced Alopecia in Postmenopausal and Premenopausal Female Breast Cancer Patients
N/A
Recruiting
170 participants
Started: Jul 6, 2022 · Completed: Jun 30, 2028
1 condition
1 sponsor
23 locations
NCT05392556
Prebiotic and Probiotic Modulation of the Gut Microbiota-gut-brain Axis During Acute Stress
NA
Recruiting
54 participants
Started: Jul 6, 2022 · Completed: Dec 31, 2025
1 condition
3 sponsors
1 location
NCT05609643
Study to Assess Change in Disease Activity and Adverse Events of RINVOQ in Adult Participants With Ankylosing Spondylitis in the Real-World Japan
N/A
Recruiting
100 participants
Started: Jul 6, 2022 · Completed: Dec 31, 2025
1 condition
1 sponsor
58 locations
NCT05378737
Evaluate the Safety, Tolerability and Pharmacokinetic Characteristics of BAT8006 for Injection
PHASE1
Recruiting
216 participants
Started: Jul 6, 2022 · Completed: Dec 31, 2025
1 condition
1 sponsor
17 locations
NCT05610566
Safety and Efficacy of the HighLife Transcatherter Mitral Valve Replacement System in Patients With Moderate-severe or Severe Mitral Regurgitation in China
NA
Recruiting
110 participants
Started: Jul 6, 2022 · Completed: Jul 6, 2029
1 condition
4 sponsors
1 location
NCT05310981
A Cannabis E-intervention for Young Cannabis Users With Early Psychosis (iCC)
NA
Active, not recruiting
100 participants
Started: Jul 6, 2022 · Completed: Jul 31, 2024
1 condition
2 sponsors
5 locations
NCT05045664
Early Stage Follicular LymphOma and RadioTherapy PLUS Anti-CD20 Antibody
PHASE3
Recruiting
100 participants
Started: Jul 6, 2022 · Completed: Dec 31, 2029
1 condition
1 sponsor
12 locations
NCT04897321
B7-H3-Specific Chimeric Antigen Receptor Autologous T-Cell Therapy for Pediatric Patients With Solid Tumors (3CAR)
PHASE1
Recruiting
32 participants
Started: Jul 6, 2022 · Completed: Mar 1, 2027
16 conditions
1 sponsor
1 location
NCT05423262
A Study of TRK-950 in Patients With Advanced Solid Tumors
PHASE1/PHASE2
Active, not recruiting
49 participants
Started: Jul 6, 2022 · Completed: Dec 31, 2027
2 conditions
1 sponsor
1 location
NCT05363267
NF-1, Nutraceutical Intervention
PHASE1
Active, not recruiting
23 participants
Started: Jul 6, 2022 · Completed: Aug 31, 2026
1 condition
1 sponsor
1 location
NCT05266976
Mode of Exercise and Bone Biomarkers in Older Veterans
NA
Recruiting
120 participants
Started: Jul 6, 2022 · Completed: Mar 31, 2027
3 conditions
2 sponsors
1 location
NCT04576091
Testing the Addition of an Anti-cancer Drug, BAY 1895344, With Radiation Therapy to the Usual Pembrolizumab Treatment for Recurrent Head and Neck Cancer
PHASE1
Active, not recruiting
7 participants
Started: Jul 6, 2022 · Completed: Dec 11, 2025
32 conditions
1 sponsor
11 locations
Previous
1
More pages
1710
1711
1712
1713
1714
1715
1716
More pages
2369
Next